Neuronetics, Inc. Common Stock

Neuronetics, Inc. Common Stock

Compare this stock

STIM Stock Report Card

$

VolatilityTechnicalsSentimentProfitPerformanceEarningsAnalyst Price Targets

44%

Performance

Score:

10/100

STIM returned -72.04% in the last 12 months. Based on SPY's performance of -13.39%, its performance is below average giving it a score of 10 of 100.

Analyst Price Targets

Score:

90/100

5 analysts offer 12-month price targets for STIM. Together, they have an average target of 8, the most optimistic target put STIM at 8 within 12-months and the most pessimistic has STIM at 8.

Sentiment

Score:

74/100

STIM had a bullish sentiment score of 74.22% across Twitter and StockTwits over the last 12 months. It had an average of 3.11 posts, 0.22 comments, and 0.44 likes per day.

Technicals

Score:

64/100

STIM receives a 64 of 100 based on 14 indicators. 8 are bullish, 4 are bearish.

Earnings

Score:

24/100

STIM has missed earnings 4 times in the last 20 quarters.

Profit

Score:

10/100

Out of the last 20 quarters, STIM has had 0 profitable quarters and has increased their profits year over year on 0 of them.

Volatility

Score:

33/100

STIM has had a lower than average amount of volatility over the last 12 months giving it a score of 33 of 100.

Neuronetics, Inc. Common Stock Summary

Nasdaq / STIM
Healthcare
Medical - Diagnostics & Research
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.